STAT | Reporting from the frontiers of health and medicine Follow FDA panel confronting peptide controversy Today's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G." https://www.statnews.com/2026/07/23/health-policy-news-today-dc-diagnosis-newsletter-john-wilkerson-2/ statnews.com
